Gelstat Stock

Gelstat Equity

The The Equity of Gelstat (GSAC) as of Aug 4, 2026 is -1.25 M USD. In the previous year, The Equity was -1.05 M USD — a change of 19.30% (lower).

Equity

-1.25 MUSD

YoY

19.30%

Last updated:

In 2026, Gelstat's equity was -1.25 M USD, a 19.30% increase from the -1.05 M USD equity in the previous year.

Access this data via the Eulerpool API

Gelstat Stock analysis

What does Gelstat do? The Gelstat Corporation is a US-American company specializing in the production of pharmaceuticals and complementary preparations. The development and marketing of products that improve well-being and health is at the center of the company's business model. The Gelstat Corporation was founded in 2004 by Dr. Thomas Smith and Dr. David Knopman. Originally, the company focused on the development of methods for the diagnosis of degenerative brain diseases. In collaboration with renowned research institutions and universities, the Gelstat Corporation was able to achieve valuable achievements in this field. In 2008, the company expanded its portfolio and began producing medications and dietary supplements. The Gelstat Corporation focused particularly on the use of ingredients that have positive effects on the body and well-being according to scientific studies. Currently, the company is divided into two main divisions: Gelstat Migraine and Gelstat Sleep. Gelstat Migraine is an over-the-counter preparation used for pain relief in migraine attacks. The product contains a high concentration of magnesium and therefore does not cause side effects such as nausea or dizziness that can occur with many other pain relievers. The use of Gelstat Migraine in combination with other medications is also safe. Gelstat Sleep is a dietary supplement taken to improve sleep quality. It contains a combination of plant-based ingredients such as valerian, passionflower, and melatonin. These active ingredients have a calming effect and can help to fall asleep and stay asleep more quickly. Gelstat Sleep is free of chemical substances and therefore suitable for long-term use. In addition to the two main divisions, Gelstat Corporation also offers other products based on natural ingredients. These include dietary supplements to strengthen the immune system, products for joint discomfort, and for improving memory performance. The goal of Gelstat Corporation is to promote the health and well-being of people in a natural way. The company ensures that all production steps are carried out under strict quality controls. The product development is also based on scientific studies and done in close collaboration with experts in the respective field. In summary, the Gelstat Corporation is an innovative company specializing in the production of pharmaceuticals and complementary preparations. The company's products are based on natural ingredients and have positive effects on the well-being and health of people. Through close collaboration with experts and strict adherence to quality standards, Gelstat Corporation has quickly made a name for itself in the industry. Gelstat is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Gelstat's Equity

Gelstat's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Gelstat's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Gelstat's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Gelstat's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Gelstat’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Gelstat stock

The Equity of Gelstat is -1.25 M USD in 2026.

The Equity of Gelstat changed from -1.05 M USD to -1.25 M USD, representing a 19.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Gelstat since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Gelstat historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Gelstat

All Key Metrics — Gelstat